Currently, the MELD 3.0 has been proposed as a replacement for the MELD‐Na (similar to UKELD) and includes gender, serum albumin, and statistical interaction between albumin, creatinine, bilirubin, and serum sodium with superior prognostic discrimination in cirrhosis (Kim et al., 2021). Here, ALB is linked to Cirrhosis.